本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 北京康比特体育科技股份有限公司（以下简称"公司"）董事会薪酬与考核 委员会于 2025 年 8 月 25 日召开 2025 年度第三次会议，根据《公司章程》、《薪 酬与考核委员会议事规则》、《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）等有关规定，董事会薪酬与 考核委员会对《2025 年股权激励计划（草案）》（以下简称"《激励计划》"）进行 了认真核查，发表如下核查意见： 一、公司不存在《管理办法》等法律法规规定的禁止实施股权激励计划的情 形，包括： 1、最近一个会计年度财务会计报告被注册会计师出具否定意见或者无法表 示意见的审计报告； 2、最近一个会计年度财务报告内部控制被注册会计师出具否定意见或者无 法表示意见的审计报告； 3、上市后最近 36 个月内出现过未按法律法规、公司章程、公开承诺进行利 润分配的情形； 证券代码：833429 证券简称：康比特 公告编号：2025-108 北京康比特体育 ...

证券代码：833429 证券简称：康比特 公告编号：2025-106 北京康比特体育科技股份有限公司 | | | 获授的股票期 | 占授予股票 | 占激励计划草案 | | --- | --- | --- | --- | --- | | 姓名 | 职务 | 权数量（万 | 期权总量的 | 公告日股本总额 | | | | 份） | 比例 | 的比例 | | 李奇庚 | 董事、总经理 | 15.25 | 7.63% | 0.12% | | 焦颖 | 董事、副总经理 | 10.00 | 5.00% | 0.08% | | 魏冰 | 职工代表董事 | 8.25 | 4.13% | 0.07% | | 朱煜 | 副总经理 | 8.35 | 4.18% | 0.07% | | 李峰玭 | 副总经理 | 11.88 | 5.94% | 0.10% | | 邢彦斌 | 副总经理 | 9.85 | 4.93% | 0.08% | | 吕立甫 | 财务总监、董事会秘书 | 9.19 | 4.60% | 0.07% | | | 核心员工（62 人） | 127.23 | 63.62% | 1.02% | | | 合计 | 200.0 ...

证券代码：833429 证券简称：康比特 公告编号：2025-102 北京康比特体育科技股份有限公司 持股 5%以上股东减持股份结果公告 本公司及董事会全体成员及相关股东保证公告内容不存在虚假记载、误导性 陈述或重大遗漏，并对其内容的真实、准确和完整承担个别及连带责任。 一、 减持主体减持前基本情况 √减持计划实施完毕 □减持时间区间届满 | | | 减持数 | | | | | 减 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 量占总 | | | | | 持 | | | | | | 股本比 | 减 | | | | 计 | | 当前持 | | 股东 | 减持数量 | 例（%） | 持 | 减持 | 减持价格区 | 已减持总金额 | 划 | 当前持股数 | 股比例 | | 名称 | （股） | | 方 | 期间 | 间 | （元） | 完 | 量（股） | （%） | | | | | 式 | | | | 成 | | | | | | | | | | | 情 | | | | | | | | | | | 况 | | | ...

本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 证券代码：833429 证券简称：康比特 公告编号：2025-101 北京康比特体育科技股份有限公司 持股5%以上股东权益变动达到1%的提示性公告 1、基本情况 | 2、本次权益变动情况 | | | | | --- | --- | --- | --- | | 股东名称 | 变动方式 | 减持股份（股） | 减持比例 | | 张炜 | 集中竞价 | 1,190,000 | 0.9558% | | 陈庆玥 | 集中竞价 | 461,200 | 0.3704% | 注：陈庆玥与持股5%以上股东张炜系夫妻关系，为持股5%以上股东一致行动人。 北京康比特体育科技股份有限公司（以下简称"公司"）于2025年8月20日 收到持股5%以上股东张炜先生及其一致行动人陈庆玥女士出具的《股份减持结果 告知函》，张炜先生于2025年8月19日至2025年8月20日通过集中竞价累计减持公 司股份1,190,000股，持有公司股份比例从9.88%减少至8.92%，一致行动人陈庆 玥女 ...

证券之星消息，8月21日食品加工板块较上一交易日上涨0.13%，康比特领涨。当日上证指数报收于 3771.1，上涨0.13%。深证成指报收于11919.76，下跌0.06%。食品加工板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 833429 | 康比特 | 23.33 | 9.38% | 10.69万 | | 2.41亿 | | 605338 | 巴比食品 | 22.20 | 3.11% | 6.75万 | | 1.49亿 | | 002626 | 金达威 | 19.30 | 1.63% | 11.08万 | | 2.13亿 | | 605567 | 春雪食品 | 11.14 | 1.36% | 4.99万 | | 5557.76万 | | 603237 | 五芳斋 | 18.04 | 0.45% | 3.36万 | | 6040.88万 | | 002726 | 龙大美食 | 5.50 | 0.36% | 25.26万 | | 1.39亿 | | 000 ...

Investment Rating - The investment rating for the company is "Accumulate" (maintained) [6] Core Views - The company's revenue from protein muscle gain business increased by 29% year-on-year, but high raw material prices have temporarily pressured profits [6] - In H1 2025, the company achieved revenue of 560 million yuan (up 10.9% year-on-year) and a net profit attributable to shareholders of 15.19 million yuan (down 67.9% year-on-year) with a gross margin of 32.2% (down 9.3 percentage points) [7] - The company plans to optimize its product sales structure and enhance the sales scale of high-margin products while maintaining its market share in the protein muscle gain sector [7] Financial Summary - The company’s total market capitalization is approximately 2,686.71 million yuan, with a circulating market capitalization of 2,444.77 million yuan [4] - The company’s total share capital is 124.50 million shares, with a debt-to-asset ratio of 31.02% and a net asset value per share of 6.73 yuan [4] - Revenue projections for 2025-2027 are 1,303 million yuan, 1,643 million yuan, and 2,060 million yuan respectively, with corresponding net profits of 810 million yuan, 1,050 million yuan, and 1,350 million yuan [8][9]

证券代码：833429 证券简称：康比特 公告编号：2025-100 北京康比特体育科技股份有限公司 持股5%以上股东权益变动达到1%的提示性公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 北京康比特体育科技股份有限公司（以下简称"公司"）于2025年8月18日 收到持股5%以上股东张炜先生及其一致行动人陈庆玥女士出具的《股份减持进展 告知函》，张炜先生于2025年7月30日通过集中竞价累计减持公司股份45,210股， 持有公司股份比例从9.92%减少至9.88%，一致行动人陈庆玥女士于2025年7月31 日至2025年8月18日期间通过集中竞价累计减持公司股份780,000股，持有公司股 份比例从2.71%减少至2.09%。 (一)信息披露义务人基本情况 | 信息披露义务人 | 名称 | 持股变动时间 | | | --- | --- | --- | --- | | 张炜、陈庆玥 | | 2025年7月30日-2025年8月18日 | | | 股票简称 | 康比特 | 证券代码 | 833429 ...

Market Overview - The market size of China's nutritional functional food industry is projected to reach CNY 2,331 billion in 2024, with an expected CAGR of 8.5% from 2024 to 2029, reaching CNY 3,499 billion by 2029[7][19]. - The overall nutritional health food market in China is expected to grow from CNY 5,223 billion in 2024 to CNY 7,203 billion in 2029, with a CAGR of 6.6% during the same period[11][14]. Industry Challenges - The per capita consumption of nutritional functional foods in China is CNY 166 in 2024, which is lower than the global average of CNY 179 and significantly below countries like the USA (CNY 754) and Japan (CNY 572)[19][22]. - The industry faces challenges such as consumer awareness, severe product homogeneity, and insufficient innovation, which hinder growth compared to more developed markets[19][20]. Investment Insights - The contract manufacturing segment of the nutritional functional food industry is expected to grow from CNY 253 billion in 2024 to CNY 441 billion by 2029, with a CAGR of 11.8%[24][27]. - Key companies listed on the Beijing Stock Exchange related to the nutritional functional food sector include Kangbiter (brand operator), Wuxi Jinghai (raw material supplier), and Hengmei Health (contract manufacturer)[28]. Market Performance - The median price change for consumer service stocks on the Beijing Stock Exchange was -2.54% from August 11 to August 15, 2025, with only 5 companies (13%) showing an increase[36][39]. - The total market capitalization of consumer service companies decreased from CNY 1,235.58 billion to CNY 1,189.40 billion during the same period[39][44]. Financial Highlights - Jinbo Bio reported a revenue of CNY 128.58 billion for 2025, a year-on-year increase of 42.43%, with a net profit of CNY 3.92 billion, up 26.65% from the previous year[56].

Investment Rating - The report maintains an "Outperform" rating for the company [2][8]. Core Insights - The company reported a revenue of 562 million yuan for H1 2025, a year-on-year increase of 10.9%, but a significant decline in net profit by 67.9% to 15 million yuan [5][8]. - The Q2 2025 revenue was 369 million yuan, reflecting a 4.3% year-on-year growth, while net profit dropped by 91.3% to 3 million yuan, indicating that revenue met market expectations but profits fell short [5][8]. - The company aims to improve profitability in H2 2025 through various measures, including increasing the sales proportion of high-margin products and enhancing cost management [8]. Financial Data and Profit Forecast - The company’s total revenue projections for 2025-2027 are adjusted to 1.28 billion yuan, 1.61 billion yuan, and 2.05 billion yuan respectively, with corresponding net profits of 95 million yuan, 112 million yuan, and 151 million yuan [7][8]. - The gross margin for H1 2025 was reported at 32.2%, a decrease of 9.3 percentage points year-on-year, while the net margin was 2.7%, down 6.6 percentage points [8]. - The company’s earnings per share (EPS) for 2025 is projected at 0.77 yuan, with a price-to-earnings (PE) ratio of 28 [7][8]. Business Performance - The core business segments showed varied performance, with sports nutrition products growing by 24.7% year-on-year, while military supply and other segments faced declines [8]. - The company’s protein muscle gain products generated 327 million yuan in revenue for H1 2025, a 29.1% increase, despite overall market challenges [8]. - The energy supplement segment is expanding, with a notable 9.2% increase in revenue from energy gels [8]. Strategic Outlook - The company plans to enhance its product structure and cost management to counteract declining net profit margins [8]. - New channel development and market expansion efforts are underway to adapt to the evolving sports nutrition consumer landscape [8].

Group 1 - The company reported a revenue of 562,420,878.62 yuan for the first half of 2025, representing a year-on-year growth of 10.92% [2] - The net profit attributable to shareholders of the listed company was 15,185,657.78 yuan, showing a year-on-year decline of 67.91% [2]